By Roshan Fernandez
Shares of Steris gained after the medical-device company beat analysts' expectations for its fourth-quarter per share results.
Shares climbed 5.5%, to $240, after hours Wednesday, and the stock is up about 11% since the beginning of the year.
The Dublin company reported a fiscal fourth-quarter profit of $145.7 million, or $1.48 a share, compared to a loss of $1.4 million, or 1 cent a share, a year earlier.
Excluding one-time items, per-share earnings were $2.74, beating analysts' expectations of $2.60, according to FactSet.
Revenue rose to $1.48 billion from $1.42 billion during the year-ago quarter. Analysts expected $1.47 billion.
That was driven in part by a rise in applied sterilization-technologies sales, which were up 9.2% compared to last year.
The company expects revenue for fiscal-year 2026 to increase 6% to 7%. That would be between about $5.79 billion to $5.84 billion, based on the $5.46 billion the company reported in revenue for fiscal-year 2025. That beats the $5.78 billion projected by analysts.
Adjusted earnings per share are expected to be between $9.90 and $10.15 for the fiscal year. Analysts were looking for $10 in adjusted per-share earnings.
Steris said its fiscal-year 2026 outlook includes an expected $30 million pre-tax hit to its profits as a result of tariffs.
Write to Roshan Fernandez at roshan.fernandez@wsj.com
(END) Dow Jones Newswires
May 14, 2025 17:59 ET (21:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。